Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer
about
Apolipoprotein A-I and CancerMetabolic syndrome and renal cell carcinomaPlant sterols as anticancer nutrients: evidence for their role in breast cancerLipid profiles and the risk of endometrial cancer in the Swedish AMORIS studyThe importance of LDL and cholesterol metabolism for prostate epithelial cell growthDecreased serum apolipoprotein A1 levels are associated with poor survival and systemic inflammatory response in colorectal cancer.Specific metabolic biomarkers as risk and prognostic factors in colorectal cancer.Statin use and cancer risk: a comprehensive reviewStatin use and risk of liver cancer: an update meta-analysis.Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH databaseHDL cholesterol and cancer risk among patients with type 2 diabetes.Total serum cholesterol and cancer incidence in the Metabolic syndrome and Cancer Project (Me-Can)Association of dyslipidemia with renal cell carcinoma: a 1∶2 matched case-control study.The role of high-density lipoproteins in reducing the risk of vascular diseases, neurogenerative disorders, and cancer.Total cholesterol and cancer risk in a large prospective study in KoreaHigh-density lipoprotein cholesterol is a favorable prognostic factor and negatively correlated with C-reactive protein level in non-small cell lung carcinoma.Metabolic Characterization of Advanced Liver Fibrosis in HCV Patients as Studied by Serum 1H-NMR SpectroscopyClinical significance of preoperative serum high density lipoprotein cholesterol levels in soft tissue sarcoma.Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort.Serum total and HDL cholesterol and risk of prostate cancerGamma-glutamyl transferase and C-reactive protein as alternative markers of metabolic abnormalities and their associated comorbidites: a prospective cohort study.Monitoring of high-density lipoprotein cholesterol level is predictive of EGFR mutation and efficacy of EGFR-TKI in patients with advanced lung adenocarcinoma.Serum lipid profiles and cancer risk in the context of obesity: four meta-analyses.Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database.Erythrocyte membrane fatty acid composition, serum lipids, and non-Hodgkin's lymphoma risk in a nested case-control study: the multiethnic cohort.The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokersThe Effect of Preoperative Apolipoprotein A-I on the Prognosis of Surgical Renal Cell Carcinoma: A Retrospective Large Sample Study.Cholesterol as a potential target for castration-resistant prostate cancer.LXR, prostate cancer and cholesterol: the Good, the Bad and the Ugly.High-density lipoprotein and prostate cancer: an overview.The real role of prediagnostic high-density lipoprotein cholesterol and the cancer risk: a concise review.Commonly used diabetes and cardiovascular medications and cancer recurrence and cancer-specific mortality: a review of the literature.Effects of cholesterol, C-reactive protein, and interleukin-6 on prostate cancer risk in a population of African ancestry.Components of metabolic syndrome and prognosis of renal cell cancer.1H NMR-based serum metabolomics reveals erythromycin-induced liver toxicity in albino Wistar rats.Apolipoproteins, lipids and risk of cancer.Dietary polyunsaturated fatty acids intake modifies the positive association between serum total cholesterol and colorectal cancer risk: the Rotterdam Study.The Comparison and Estimation of the Prognostic Value of Lipid Profiles in Patients With Prostate Cancer Depends on Cancer Stage Advancement.Does metabolic syndrome or its components associate with prostate cancer when diagnosed on biopsy?Saturated fat intake and prostate cancer aggressiveness: results from the population-based North Carolina-Louisiana Prostate Cancer Project.
P2860
Q26776188-3430591F-D176-42D8-9847-DE91DE0A4B23Q26825147-381AC209-5B0E-40EB-A61B-B94EA85290C6Q26861053-070C34B3-DB5F-4DEA-8B74-CCB75EAFB870Q28385524-64676014-810F-4D89-A15B-F9133999A9C7Q28727920-EACBA198-E039-4051-82C7-713C4724272DQ33905987-0857EFBE-A96A-4434-AC73-A521375D0913Q34008787-3DD7A304-4847-4E52-8935-D823CC006F1EQ34021312-E3D7061C-0294-4182-ABAA-C949A0788644Q34198230-C1DBCFBA-AFA8-4141-B1B8-C52136958684Q34458822-4FE93B0D-8C3A-4B75-B2C0-510DA701C268Q34545361-83664ACB-E792-4DBC-8082-845D3847409BQ34571058-2E5A528C-3F96-4451-B52A-ED641C62E202Q34639797-66EDA57F-6A30-430C-A920-86C3C36ABC82Q34730815-3C4A61E9-416C-4DE0-B28B-55E36A6F3A6DQ34866268-03BB841A-D876-4EED-AC2A-11A2B63243D8Q35119830-8472EFCA-7C35-4EDF-A4B3-1136924D32E8Q36012032-8315C64D-F4C4-4539-B403-77AAC36CEB64Q36151318-CFDE653C-E277-4A0F-899E-50EA74C545AEQ36334462-2301EDB6-619B-4448-A2C4-0B7BF203A145Q36407365-899D49F1-1D9B-4AD3-8DE6-1D6A9BEC71BEQ36429561-CB6864C6-7235-425F-A2EA-991B3C004BD2Q36514558-DC1A7F24-C9D4-42A9-B22A-860246B7B4D2Q36584255-8512DE3F-9486-4414-A01B-B2D067372C04Q36655971-58AE4EE2-5C64-4DE8-8659-5EA206E873F6Q37147231-17BFFDAA-9BB9-4676-BCBC-15889DCDB570Q37185740-593B7A24-A2A9-49AE-8665-A99B4D313689Q37205399-B0DDD88C-AECD-44AE-8FB5-7529978B00CEQ37777663-C694BF50-CFE4-456B-9208-F93E8A41F6E2Q38077536-8B10F0B5-7ED7-4D28-A3BA-678DA7A110A9Q38132333-A208A7D2-8282-4083-9E5E-D6780E32E772Q38151145-A4850D16-CCBD-46A6-BD0F-E87A05339E97Q38226775-E3665E95-B43A-4962-9760-3B19C19B665FQ38597093-B218D556-B58D-4351-93F0-0070FB9CBE24Q38661937-56170702-748E-43F4-B24E-2A707207F4DBQ38755446-8BFCECD5-DE13-42FC-818B-413F2A1310D1Q38916878-D18F8293-59F1-4F48-B38A-7C75F7C9E3BCQ39966939-62C8902D-3EE6-4E15-8E65-31AEC4E20DA1Q40115477-D701DFF3-0A39-4605-BB6B-CCE76F328020Q40262619-32AF42C2-1EE3-4FA6-9176-5C11CA03C3B6Q40594467-18547A54-4754-4286-9D9C-F55AF6D7ABCA
P2860
Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer
@ast
Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer
@en
type
label
Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer
@ast
Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer
@en
prefLabel
Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer
@ast
Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer
@en
P2860
P50
P1476
Prediagnostic total and high-density lipoprotein cholesterol and risk of cancer
@en
P2093
Stephanie J Weinstein
P2860
P304
P356
10.1158/1055-9965.EPI-08-1248
P577
2009-11-03T00:00:00Z